Bizarre Patents
Decorative Jeweled Wheel Cover
An improved wheel is provided wherein decorative items such as gem stones are embedded in either the wheel surface, a special mounting section attached to the wheel surface, or to a spoke strap that wraps around each spoke and positions embedded gem stones on the outside surface of the spoke.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 7345180 | Compound inhibiting dipeptidyl peptidase IV A dipeptidyl peptidase IV inhibitor which is satisfactory in respect of activity, stability and safety and has an excellent action as a pharmaceutical agent. A compound represented by the following general formula or a pharmaceutically acceptable salt thereof: | 03/18/2008 |
| 7291594 | GLP-1 derivative and preparation thereof absorbable via mucous membrane A GLP-1 derivative is provided including an amino acid sequence of GLP-1 (7-35) having deletion, substitution and/or addition of one or more amino acids and having Waa-(Xaa)n-Yaa (in which Waa is Arg or Lys, Xaa is Arg or Lys, n is an integer of 0 to 14, and Yaa is ... | 11/06/2007 |
| 7156631 | Apparatus for manufacturing a molded product, and molded product that can be manufactured with the apparatus The present invention provides a rotary press that allows mass production of a molded product. The rotary press has upper and lower punches that may be split in to a plurality of split punches, a means for moving the split punches, and a means for manipulating the p... | 01/02/2007 |
| 7132072 | Method for producing multi-cored molded article To manufacture a multi-core press-coated molded product efficiently and in a single step from molding materials, namely, powder or granular particles, a punch has been devised that is characterized in that the punch, consists of a center punch whose tip portion is s... | 11/07/2006 |
| 7081473 | Agent for preventing/ameliorating obesity comprising methylidene hydrizide compound as active ingredient The present invention provides a low-molecular inhibitor of GIP functions and, further, an agent for preventing/ameliorating obesity based on inhibition of GIP functions, which comprises, as an active ingredient, a compound represented by the following general formu... | 07/25/2006 |
| 6998407 | Antagonists of MCP-1 function and methods of use thereof Chemical compounds which are antagonists of Monocyte Chemoattractant Protein-1 (MCP-1) function, pharmaceutical compositions comprising these compounds, methods of treatment employing these compounds and compositions, and processes for preparing these compounds. The... | 02/14/2006 |
| 6962926 | Antagonist of MCP-1 function, and compositions and methods of use thereof Compounds of formula A and formula B: and their pharmaceutically acceptable salts, compositions comprising them, methods for their use, and their use in the preparation of medicaments. The compounds are antagonists of ... | 11/08/2005 |
| 6809113 | Antagonists of MCP-1 function and methods of use thereof Compounds which are antagonists of MCP-1 function and are useful in the prevention or treatment of chronic or acute inflammatory or autoimmune diseases, especially those associated with aberrant lymphocyte or monocyte accumulation such as arthritis, asthma, atherosc... | 10/26/2004 |
| 5733877 | Pharmaceutical composition containing biologically active peptide or protein A pharmaceutical composition is disclosed comprising a fat emulsion containing microspheres and having its electric charge adjusted to a negative value and a biologically active substance selected from the group consisting of a basic peptide and a basic p... | 03/31/1998 |
| 5621003 | Maillard reaction inhibitor A maillard reaction inhibitor comprising, as the principal component, an eight-structural polymer of 3-oxygermylpropionic acid represented by the following stereostructure (I): ##STR1## wherein R represents --CH2 CH2 COOH, and m... | 04/15/1997 |
| 5539125 | 1-azabicyclo[3.3.0]octan derivative, salt thereof, process for the preparation of same and use thereof as hypermotility agents There are disclosed a 1-azabicyclo[3.3.0]octan derivative of the formula ##STR1## wherein n is an integer of 1-5; and Ar is an aromatic residue. a pharmacologically acceptable salt of the compound, a process for the preparation of the compound and sa... | 07/23/1996 |
| 5536812 | Calcitonin analogue and use thereof The invention provides a polypeptide of calcitonin analogue and use thereof. The polypeptide has such an amino acid sequence that proline-amide residue (Pro-NH2) at C-terminal of native eel calcitonin is substituted to a homoserine amide residu... | 07/16/1996 |
| 5532272 | 3-oxygermylpropionic acid polymer, pharmaceutical composition containing same and method of preventing and/or curing symptoms of immune diseases using same A novel, eight structural polymer of 2-oxygermylpropionic acid having an empirical formula of C6 H10 Ge2 O7, a minimum constitutional unit of (O1/2)3 GeCH2 CH2 COOH and the... | 07/02/1996 |
| 5521157 | Modified polypeptide compound with VIP-like activity The modified polypeptide compound of the present invention is represented by the following general formula ((SEQ ID NO: 2)-X): His-Ser-Asp-Ala-Val-Phe-Thr-Gly-Asn-Tyr-Thr-Lys-Leu-Arg-Lys-Gln-Leu-Ala-Ala -Lys-Lys-Tyr-Leu-R1 -Lys-Ala-Leu-R2 ... | 05/28/1996 |
| 5502209 | Benzopyrancarboxamide derivatives, salts thereof, process for the preparation of same and use thereof There are disclosed a benzopyrancarboxamide derivative of the formula ##STR1## wherein R1 is hydrogen atom or a lower alkyl group; R2 is hydrogen atom, a lower alkyl group, halogen atom, an amino radical or an acylamino group; R... | 03/26/1996 |
| 5468728 | Use of orally absorbable motilin preparations to enhance motility of digestive tract A readily absorbable type of motilin preparation containing a motilin-like active substance and a surface active agent is provided, in which the motilin-like active substance is mainly L-leucine-13-motilin-homoserine, and the surface active agent is selec... | 11/21/1995 |
| 5364533 | Process for separating serum and plasma A process for separating and recovering serum and plasma components from a whole blood sample including passing a whole blood sample through a separating filter formed of a blood cell separating layer composed mainly of fibers impregnated with a coating a... | 11/15/1994 |
| 5356880 | Glycyrrhetinic acid derivatives The invention provides a novel glycoside which contains as the aglycon a 4-(substituted phenyl)piperazine-1-yl derivative of glycyrrhetinic acid and 11-deoxo-glycyrrhetinic acid or their derivative as well as a composition for the treatment of virus infec... | 10/18/1994 |
| 5340806 | Composition containing organogermanium compound and immunity adjusting agent comprising the composition A composition comprising an organogermanium compound represented by the formula ##STR1## wherein n is an integer of 1 or more, R is hydrogen, alkyl, --COOH, --COOR', phenyl, ##STR2## and R' is a lower alkyl and a high molecular carrier, as ... | 08/23/1994 |
| 5336688 | Composition containing organogermanium compound and immunity adjusting agents comprising the compositions A composition comprising an organogermanium compound represented by the formula ##STR1## wherein n is an integer of 1 or more, R is hydrogen, alkyl, --COOH, --COOR', phenyl, ##STR2## and R' is a lower alkyl and a high molecular carrier, as ... | 08/09/1994 |
| 5290679 | Method of predicting threatened premature delivery in a pregnant woman Even when the specimen contains human granulocyte elastase in the form of a mixture of free elastase with an elastase-inhibitor complex or complexes, the present invention enables the total quantity of elastase in that specimen to be precisely detected. T... | 03/01/1994 |
| 5279835 | Binder-free orally administrable tablet containing 3-oxygermylpropionic acid A 3-oxygermylpropionic acid preparation is provided, which activates the action of 3-oxygermylpropionic acid having the general formula: [(O1/2)3 GeCH2 CH2 COOH]n wherein n=an integer of at least 1 and is readily sol... | 01/18/1994 |
| 5260056 | Composition for enhancing biosynthesis of interferon An organic germanium compound to be effectively used for curing AIDS or making AIDS asymtomatic in various forms is expressed by the following rational formula: ##STR1## wherein n is an integer of 1 or 2 or more, is in the form of a white acicul... | 11/09/1993 |
| 5260064 | Percutaneous-administration-type pharmaceutical preparation of nitroglycerin A percutaneous-administration-type pharmaceutical preparation of nitroglycerin is provided. The preparation comprises a backing that is impervious to medicines, and a pressure-sensitive adhesive layer that is placed on one surface of said backing, wherein... | 11/09/1993 |
| 5196303 | Cloning of DNA encoding transcription factor S-II and utilization of the DNA A cloned single-strand DNA encoding amino acid sequence for a eukaryotic transcription factor S-II is disclosed together with, a cloned double-strand DNA consisting of the single-strand DNA and its complementary single-strand DNA, a DNA fragment of the si... | 03/23/1993 |
| 5180739 | Use of 3-oxygermylpropionic acid to treat and prevent diabetes-dependent type of autoimmune diseases A pharmaceutical composition is used to treat and prevent a diabetes-dependent type of autoimmune diseases, said pharmaceutical composition comprising a therapeutically effective amount of 3-oxygermylpropionic acid represented by the following formula: [(... | 01/19/1993 |
| 5177102 | Polyisoprene compounds and salts thereof There are given disclosures on a polyisoprene compound of the formula ##STR1## wherein Y is S, O, NH or ##STR2## l is an integer of 2-10, Z is a group of ##STR3## R1 and R2 are same or different and each mea... | 01/05/1993 |
| 5166388 | Stabilized composition of phytic acid A stabilized composition of phytic acid is obtained by the steps of: heating and drying rice bran de-fatted by pressing; adding acidic water of pH 3 to 5 to the dried rice bran, stirring the solution and completing the stirring before the pH of the solution reaches... | 11/24/1992 |
| 5155125 | Method of treating gastrointestinal ulcers with spiro hydantoins A therapeutic preparation for ulcers contains as a primary ingredient a compound having an aldose reductase inhibitory activity and can accelerate dermal metabolism. That compound may be d-6-fluoro-2,3-dihydro-2',5'-dioxo-spiro [4H-1-benzopyran-4,4'-... | 10/13/1992 |
| 5118789 | Antibacterial polypeptides from Sarcophaga peregrina An antibacterial polypeptide is disclosed, which is immunologically produced by Sarcophaga peregrina, when the insect is injured in its body wall. The polypeptide has a molecular weight of about 7000.... | 06/02/1992 |
| 5089265 | Stabilized phytic acid compositions A stabilized phytic acid composition is provided, which comprises phytic acid or its salt and at least one stabilizer selected from the group consisting of a product obtained by the lactic fermentation and ripening of rice bran, a water-soluble polymer ca... | 02/18/1992 |
| 5059594 | Phytic acid compositions A novel composition contains phytic acid and ferric ions as main ingredients and carboxylic acid ions as a dissolution accelerator, and may further include at least one or more or two additives selected from the group consisting of a carboxylic acid or it... | 10/22/1991 |
| 5055392 | Cloning of DNA encoding transcription factor S-11 A cloned single-strand DNA encoding amino acid sequence for a eukaryotic transcription factor S-11 is disclosed together with, a cloned double-strand DNA consisting of the single-strand DNA and its complementary single-strand DNA, a DNA fragment of the si... | 10/08/1991 |
| 4971799 | Percutaneous-administration-type pharmaceutical preparation of nitroglycerin A percutaneous-administration-type pharmaceutical preparation of nitroglycerin comprising a backing that is impervious to medicines, and a pressure-sensitive adhesive layer that is disposed on one surface of the backing, wherein the pressure-sensitive adh... | 11/20/1990 |
| 4960756 | Lectin like protein substance, method of obtaining same and anti-tumor agent comprising same A lectin like protein substance, method of obtaining same and a pharmaceutical agent containing the substance, as an effective ingredient. The substance is obtained through steps of cultivating a cell line stablished from Sarcophaga peregrina embryo to pr... | 10/02/1990 |
| 4914121 | 3-Phenyl-1-phenylpyrazole-4 acetic acid compounds which are useful in treating immune diseases A pharmaceutical composition comprising as an effective ingredient, a pyrazole compound of the formula ##STR1## wherein each of R1 and R2 is phenyl or p-halogenophenyl radical, respectively, and R3 is hydrogen atom or... | 04/03/1990 |
| 4871740 | Glycyrrhetic acid derivatives and use thereof A glycyrrhetic acid derivative of the formula ##STR1## wherein X and Y are hydrogen atom, respectively or X is oxygen atom together with Y, A1 is methylene or carbonyl radical, A2 is hydrogen atom, cyano, carbamoyl, carboxyl rad... | 10/03/1989 |
| 4868189 | Uracil derivatives for use as anti-tumor agents having silicon containing side chains An organo-silicone compound of the formula ##STR1## wherein X is a methylene or carbonyl radical, Y is an NH or O, n is an integer, R1 is a hydrogen atom, halogen atom or alkyl group, R2, R3 and R4 are an a... | 09/19/1989 |
| 4857521 | Trialkylsilyl pyridinium cephalosporin antibiotics A cephalosporin derivative represented by the formula ##STR1## wherein R is an organic residue known on ଲ-lactam antibiotics and Q is a radical of ##STR2## dotted-line means a possible double bond, R1 is hydrogen or monova... | 08/15/1989 |
| 4604234 | Protein having cell growth stimulating action, composition thereof and method for producing the same A protein effective in stimulating cell growth activity. The protein has a molecular weight of from 5,000 to about 160,000, is composed predominantly of neutral and acidic amino acids, contains a significant amount of glutamic acid and aspartic acid, and ... | 08/05/1986 |
